Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHL.L Regulatory News (RHL)

  • There is currently no data for RHL

Nuclear Contract Win

22 Mar 2007 07:01

Redhall Group PLC22 March 2007 Immediate Release 22 March 2007 Redhall Group plc ("Redhall" or "the Group") Awarded £5.9 million THORP nuclear contract Redhall Group plc, the specialist engineering support services group, is pleasedto announce that its nuclear engineering and decommissioning division, JORDANNUCLEAR has secured a £5.9 million 12 month contract with British Nuclear GroupSellafield Limited for work on the Sellafield Thermal Oxide Reprocessing Plant(THORP). JORDAN NUCLEAR was established in 1964 and has operated in the nuclear industryfor over 40 years. It supplies, installs and commissions mechanical andelectrical plant and is a leading player in the UK nuclear decommissioningindustry. The works comprise installation of a Medium Salt Free Evaporator which includesinstallation design, and the supply and installation of associated vessels,modules, plant and pipework. THORP was opened in 1994 to reprocess oxide fuelfrom advanced gas cooled and light water reactors. Commenting on the contract win, David Jackson, Group Executive Chairman said; "Iam delighted that JORDAN NUCLEAR has secured such a high profile contract atSellafield which is recognition by British Nuclear Group of its technicalcapabilities in the nuclear arena." For more information please contact: Redhall Group plc Tel: +44 (0)1924 385 386David Jackson, Chairman and Chief ExecutiveSimon Foster, Deputy Chief Executive Buchanan Communications Tel: +44 (0)20 7466 5000Isabel Podda / James Strong This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Oct 20089:31 amRNSEPT Disclosure
15th Oct 20084:57 pmRNSEPT Disclosure
15th Oct 20089:49 amRNSEPT Disclosure
14th Oct 20089:32 amRNSEPT Disclosure
10th Oct 20084:59 pmRNSEPT Disclosure
9th Oct 20085:08 pmRNSEPT Disclosure
7th Oct 20088:14 amRNSEPT Disclosure
3rd Oct 20085:15 pmRNSAmended EPT Disclosure
3rd Oct 20085:00 pmRNSEPT Disclosure
3rd Oct 20089:22 amRNSEPT Disclosure
1st Oct 20088:34 amRNSEPT Disclosure
30th Sep 20084:19 pmRNSOffer Document Posted
30th Sep 20088:09 amRNSCORRECTION to Proposed Acquisition
30th Sep 20087:01 amRNSProposed Acquisition
30th Sep 20087:01 amRNSProposed Placing
19th Sep 200810:06 amRNSChange of Adviser
11th Sep 20081:20 pmRNSHolding(s) in Company
27th Aug 20087:45 amRNSHolding(s) in Company
15th Aug 20087:00 amRNSBoard Appointment
28th Jul 200812:56 pmRNSHolding(s) in Company
24th Jul 20089:36 amRNSHolding(s) in Company
23rd Jul 20087:00 amRNSKey Contracts Signed
18th Jul 20083:21 pmRNSOption Extension
4th Jul 200811:40 amRNSHolding(s) in Company
30th Jun 20082:39 pmRNSHolding(s) in Company
25th Jun 20084:54 pmRNSHolding(s) in Company
11th Jun 20087:00 amRNSDirector/PDMR Shareholding
5th Jun 20087:00 amRNSInterim Results
22nd May 20087:00 amRNSPreferred Bidder
6th May 20081:00 pmRNSHolding(s) in Company
2nd May 20083:19 pmRNSHolding(s) in Company
14th Apr 200812:22 pmRNSAdoption of IFRS
10th Apr 20085:42 pmRNSHolding(s) in Company
9th Apr 20085:55 pmRNSHolding(s) in Company
3rd Apr 20087:00 amRNSPre-Close and Alliance
2nd Apr 200810:34 amRNSHolding(s) in Company
20th Mar 20082:00 pmRNSDirector/PDMR Shareholding
6th Mar 20083:09 pmRNSHolding(s) in Company
21st Feb 20082:13 pmRNSResult of AGM
21st Feb 20087:05 amRNSAGM Statement
21st Feb 20087:01 amRNSBoard Appointment
30th Jan 20083:11 pmRNSHolding(s) in Company
23rd Jan 200812:49 pmRNSDirector/PDMR Shareholding
15th Jan 20089:44 amRNSDirector/PDMR Shareholding
15th Jan 20087:00 amRNSChange of Broker
13th Dec 20071:40 pmRNSDirector/PDMR Shareholding
6th Dec 20077:01 amRNSPreliminary Results
29th Nov 20077:01 amRNSHolding(s) in Company
14th Nov 20077:01 amRNSDirectorate Change
12th Nov 200712:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.